An internal standard for the quantification of bicalutamide
Related Products
Unlabeled Version(s)
14250Bicalutamide
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Bicalutamide-d4

Item No. 22377

Technical Information
Formal Name
N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl-2,3,5,6-d4)sulfonyl]-2-hydroxy-2-methyl-propanamide
CAS Number
1185035-71-5
Molecular Formula
C18H10D4F4N2O4S
Formula Weight
Purity
≥99% deuterated forms (d1-d4)
Formulation
A solid
DMSO: SolubleMethanol: Soluble
SMILES
OC(CS(C1=C([2H])C([2H])=C(F)C([2H])=C1[2H])(=O)=O)(C)C(NC2=CC(C(F)(F)F)=C(C#N)C=C2)=O
InChi Code
InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)/i3D,4D,6D,7D
InChi Key
LKJPYSCBVHEWIU-ZDPIWEEJSA-N
Shipping & Storage Information
Storage
4°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Bicalutamide-d4 is intended for use as an internal standard for the quantification of bicalutamide (Item No. 14250) by GC- or LC-MS. Bicalutamide is a non-steroidal androgen receptor antagonist that binds the androgen receptor (Ki = 12.5 μM; IC50 = 1.2 μM), preventing its activation and subsequent upregulation of androgen responsive genes by androgenic hormones.1,2 Bicalutamide is frequently used to examine the role of androgen receptor inactivation in the proliferation of prostate cancer cells and has served as a molecular template for the design and structural optimization of more selective androgen receptor modulators for androgen therapy.3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Freeman, S.N., Mainwaring, W.I.P., and Furr, B.J.A. A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen, Casodex (ICI 176,334). Br. J. Cancer 60(5), 664-668 (1989).

    2. Masiello, D., Cheng, S., Bubley, G.J., et alBicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. The Journal of Biological Chemisty 277(29), 26321-26326 (2002).

    3. Gao, W., Kim, J., and Dalton, J.T. Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands. Pharmacol. Res. 23(8), 1641-1658 (2006).

    4. Yin, D., Perera, M.A., Dalton, J.T., et alKey structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Mol. Pharmacol. 63(1), 211-223 (2003).